> Markdown version of [/jobs/ext/4212344-director-us-bd-l-and-commercial-mergers-integrations](https://www.wearedevelopers.com/jobs/ext/4212344-director-us-bd-l-and-commercial-mergers-integrations). Every page supports `.md` or `Accept: text/markdown`. Links point to the HTML versions so they work for humans too. Agent guide: [/agents.md](https://www.wearedevelopers.com/agents.md).

---

# Director, US BD&L and Commercial Mergers & Integrations

- **Company:** Novartis Group
- **Location:** East Hanover, NJ, United States
- **Experience:** Expert
- **Salary:** $176,400.0 - $327,600.0
- **Contract:** Permanent contract
- **Skills:** Microsoft Access, Data Analysis, Systems Integration
- **Published:** October 14, 2026
- **Apply:** https://diversityjobs.com/career/18638355/Director-Us-Bd-L-Commercial-Mergers-Integrations-New-Jersey-East-Hanover

## About the Role

* Bachelor's Degree required; MBA, scientific, clinical, or health policy degree preferred.
 * 8+ years of relevant pharmaceutical industry experience, such as commercial strategy, BD&L, pipeline strategy, insights and analytics, modeling, finance, access, or related functions.
 * Strong understanding of the commercialization process, pipeline assessment, coverage and reimbursement considerations, and cross-functional decision-making.

Desirable Requirements:

 * Cardiovascular/Cardiology expertise preferred, ideally through scientific, clinical, pipeline, commercial, or BD&L experience., Alliance Management, Biosimilar Drugs (Inactive), Business Development, Business-To-Business (B2B) Software, Collaboration, Creativity, Customer Experience (CX), Due Diligence, Evaluation (Inactive), Financial Modeling, Global Business Development, Intellectual Property, Mergers and Acquisitions (M&A), Online Learning, Promotion Marketing, Sales, Scouting (Inactive), Search (Inactive), Selling Skills (Inactive), Transactions (Inactive)

## Description

The Director, US BD&L will work under the leadership of the ED US BD&L and Commercial Mergers & Integrations to partner with the an extended team of US cross functional experts providing strategic support across therapeutic areas, with a preference for candidates who bring relevant expertise through scientific, clinical, pipeline, commercial, or BD&L experience. This individual will help ensure strong US perspective and alignment across asset assessments, opportunity prioritization, and cross-functional input, while supporting effective partnership with the global team in Strategy and growth (BD&L) as well as the M&A group.

The Director, US BD&L will offer strategic support in an agile way, depending on the priorities.

This leader is expected to demonstrate accountability and responsibility for broader enterprise leadership in her/his decisions and engagement across the US Pharma organization and the Global Pharma Organization.

This leader has a passion for transformational enterprise leadership, decisive strategy in service of delivering higher impact for patients, customers, healthcare systems with higher quality, speed and agility., * Coordinate clear and timely US input across TA pipeline leads and relevant line functions to support high-quality BD&L assessments and recommendations.

 * In close collaboration with the data and insights team, integration of insights and recommendation for all sources of external data, including analysts' reports, enterprise level competitive intelligence
 * Serve as an effective bridge between US stakeholders, Strategy & Growth, TASH, and Global teams to ensure aligned, actionable, and well-integrated US perspectives.
 * Lead cross-TA coverage, with a preferred core focus and deeper expertise in Cardiovascular/Cardiology and related pipeline areas, while remaining flexible and able to integrate knowledge across other therapeutic areas, including Neuroscience, Oncology, and Im-munology, as US BD&L priorities, bandwidth, and business needs evolve.
 * Support merger, acquisition, and integration preparedness by contributing to coordinated US BD&L input, while demonstrating the agility, operational discipline, and people-management skills needed to pivot and support integration work during an acquisition or other priority enterprise initiatives.